Asianet Newsable on MSN
Exicure stock soars 40% after stem cell drug helps most patients hit phase 2 goal — traders call it 'cheap' at current levels
Shares of Exicure Inc. (XCUR) surged nearly 40% on Tuesday after the company reported encouraging Phase 2 results for its ...
Stocks and bonds wavered while traders held off from making big bets ahead of the Federal Reserve’s final interest-rate ...
2hon MSN
Microsoft and Providence create AI that unlocks tumor insights at a scale previously out of reach
Tech and cancer researchers are publicly releasing an AI tool that can perform sophisticated tumor analysis in a fraction of the time and cost of existing methods.
Exicure shares trade higher after Phase 2 data show nearly 90% of patients reached key cell collection targets using its ...
Blackstone expected to launch a sale process for Sabre Industries, a manufacturer of steel utility poles and support ...
Stocks made small advances while traders held off from making big bets ahead of the Federal Reserve’s final interest-rate ...
The National Kidney Foundation states that millions of people are suffering from kidney diseases and mostly because of ...
City of Hope to Evaluate PEDMARK® for Reducing Ototoxicity in Adult Men with Stage II-III Metastatic Testicular Germ Cell Tumors – ...
Android: Hold down the power button, or the power button and the volume down key (depending on your Android phone), until the ...
Aggressive T-cell lymphoma is a rare and devastating form of blood cancer with a very low five-year survival rate.
Researchers from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the nation’s top ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback